| Silver Oak Medical Office Inc | |
|
702 Mountain Ranch Rd San Andreas CA 95249 | |
| (209) 754-0870 | |
| (209) 754-0878 |
| Full Name | Silver Oak Medical Office Inc |
|---|---|
| Speciality | Surgery |
| Location | 702 Mountain Ranch Rd, San Andreas, California |
| Authorized Official Name and Position | Peter Forrest Oliver (MD PRESIDENT) |
| Authorized Official Contact | 2097540870 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Silver Oak Medical Office Inc Po Box 636 San Andreas CA 95249 Ph: (209) 754-0870 | Silver Oak Medical Office Inc 702 Mountain Ranch Rd San Andreas CA 95249 Ph: (209) 754-0870 |
| NPI Number | 1730125121 |
|---|---|
| Provider Enumeration Date | 06/22/2006 |
| Last Update Date | 07/12/2010 |
| Medicare PECOS PAC ID | 1153306022 |
|---|---|
| Medicare Enrollment ID | O20040623001192 |
News Archive
The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.
There are so many stories around alcohol and drinking that it's hard to know what to believe.
Taiwanese researchers have found differences in fronto-limbic metabolism and executive function between patients with bipolar disorder I and II.
The U.S. Food and Drug Administration today approved Hiberix, a Haemophilus influenzae Type b (Hib) vaccine, as a booster dose for children 15 months through 4 years old. Hiberix is manufactured by GlaxoSmithKline, with U.S. headquarters in Research Triangle Park, N.C. and Philadelphia.
NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that Pharma Lynx, a global contract research organization and a subsidiary of Diverse Lynx, has signed an MSA to license NewCardio's QTinno™ solution for use in Phase 1 studies. Pharma Lynx has particular expertise in oncology studies, including QTc studies involving both healthy subjects and cancer patients, and QTinno will add to Pharma Lynx's already robust capabilities, enabling it to deliver fully automated QTc studies to its sponsors.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730125121 | NPI | - | NPPES |
| Provider Name | Sarah Margaret Grimes |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1922037563 PECOS PAC ID: 2264418706 Enrollment ID: I20040625000895 |
News Archive
The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.
There are so many stories around alcohol and drinking that it's hard to know what to believe.
Taiwanese researchers have found differences in fronto-limbic metabolism and executive function between patients with bipolar disorder I and II.
The U.S. Food and Drug Administration today approved Hiberix, a Haemophilus influenzae Type b (Hib) vaccine, as a booster dose for children 15 months through 4 years old. Hiberix is manufactured by GlaxoSmithKline, with U.S. headquarters in Research Triangle Park, N.C. and Philadelphia.
NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that Pharma Lynx, a global contract research organization and a subsidiary of Diverse Lynx, has signed an MSA to license NewCardio's QTinno™ solution for use in Phase 1 studies. Pharma Lynx has particular expertise in oncology studies, including QTc studies involving both healthy subjects and cancer patients, and QTinno will add to Pharma Lynx's already robust capabilities, enabling it to deliver fully automated QTc studies to its sponsors.
› Verified 3 days ago
| Provider Name | Dean M Kelaita |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1750310496 PECOS PAC ID: 5092791541 Enrollment ID: I20040625000955 |
News Archive
The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.
There are so many stories around alcohol and drinking that it's hard to know what to believe.
Taiwanese researchers have found differences in fronto-limbic metabolism and executive function between patients with bipolar disorder I and II.
The U.S. Food and Drug Administration today approved Hiberix, a Haemophilus influenzae Type b (Hib) vaccine, as a booster dose for children 15 months through 4 years old. Hiberix is manufactured by GlaxoSmithKline, with U.S. headquarters in Research Triangle Park, N.C. and Philadelphia.
NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that Pharma Lynx, a global contract research organization and a subsidiary of Diverse Lynx, has signed an MSA to license NewCardio's QTinno™ solution for use in Phase 1 studies. Pharma Lynx has particular expertise in oncology studies, including QTc studies involving both healthy subjects and cancer patients, and QTinno will add to Pharma Lynx's already robust capabilities, enabling it to deliver fully automated QTc studies to its sponsors.
› Verified 3 days ago
| Provider Name | Peter F Oliver |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1609812965 PECOS PAC ID: 9032194915 Enrollment ID: I20040625001103 |
News Archive
The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.
There are so many stories around alcohol and drinking that it's hard to know what to believe.
Taiwanese researchers have found differences in fronto-limbic metabolism and executive function between patients with bipolar disorder I and II.
The U.S. Food and Drug Administration today approved Hiberix, a Haemophilus influenzae Type b (Hib) vaccine, as a booster dose for children 15 months through 4 years old. Hiberix is manufactured by GlaxoSmithKline, with U.S. headquarters in Research Triangle Park, N.C. and Philadelphia.
NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that Pharma Lynx, a global contract research organization and a subsidiary of Diverse Lynx, has signed an MSA to license NewCardio's QTinno™ solution for use in Phase 1 studies. Pharma Lynx has particular expertise in oncology studies, including QTc studies involving both healthy subjects and cancer patients, and QTinno will add to Pharma Lynx's already robust capabilities, enabling it to deliver fully automated QTc studies to its sponsors.
› Verified 3 days ago
| Provider Name | Andrew Mccoy |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1780883025 PECOS PAC ID: 2961646195 Enrollment ID: I20141016001461 |
News Archive
The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.
There are so many stories around alcohol and drinking that it's hard to know what to believe.
Taiwanese researchers have found differences in fronto-limbic metabolism and executive function between patients with bipolar disorder I and II.
The U.S. Food and Drug Administration today approved Hiberix, a Haemophilus influenzae Type b (Hib) vaccine, as a booster dose for children 15 months through 4 years old. Hiberix is manufactured by GlaxoSmithKline, with U.S. headquarters in Research Triangle Park, N.C. and Philadelphia.
NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that Pharma Lynx, a global contract research organization and a subsidiary of Diverse Lynx, has signed an MSA to license NewCardio's QTinno™ solution for use in Phase 1 studies. Pharma Lynx has particular expertise in oncology studies, including QTc studies involving both healthy subjects and cancer patients, and QTinno will add to Pharma Lynx's already robust capabilities, enabling it to deliver fully automated QTc studies to its sponsors.
› Verified 3 days ago
News Archive
The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.
There are so many stories around alcohol and drinking that it's hard to know what to believe.
Taiwanese researchers have found differences in fronto-limbic metabolism and executive function between patients with bipolar disorder I and II.
The U.S. Food and Drug Administration today approved Hiberix, a Haemophilus influenzae Type b (Hib) vaccine, as a booster dose for children 15 months through 4 years old. Hiberix is manufactured by GlaxoSmithKline, with U.S. headquarters in Research Triangle Park, N.C. and Philadelphia.
NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that Pharma Lynx, a global contract research organization and a subsidiary of Diverse Lynx, has signed an MSA to license NewCardio's QTinno™ solution for use in Phase 1 studies. Pharma Lynx has particular expertise in oncology studies, including QTc studies involving both healthy subjects and cancer patients, and QTinno will add to Pharma Lynx's already robust capabilities, enabling it to deliver fully automated QTc studies to its sponsors.
› Verified 3 days ago
Mountain Oak Health Centers Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 556 Mountain Ranch Road, San Andreas, CA 95249 Phone: 209-498-2014 Fax: 209-498-2143 | |
Galen Inpatient Physicians, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 768 Mountain Ranch Rd, San Andreas, CA 95249 Phone: 209-754-3521 | |
Family Medical Center - San Andreas Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 704 Mountain Ranch Rd, San Andreas, CA 95249 Phone: 209-754-3521 | |
Mark Twain Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 768 Mountain Ranch Rd, San Andreas, CA 95249 Phone: 209-754-3521 Fax: 209-754-2652 | |
Gold Rush Inpatient Services, A Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 768 Mountain Ranch Rd, San Andreas, CA 95249 Phone: 209-754-3521 | |
Mact Medical San Andreas Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1113 Hwy 49, San Andreas, CA 95249 Phone: 209-755-1400 Fax: 209-755-1430 | |
M A C T Health Board Incorporated Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1113 Highway 49, San Andreas, CA 95249 Phone: 209-754-6262 Fax: 209-674-6211 |